ARLINGTON, Va. – During remarks at the National Association of Chain Drug Stores Annual Meeting Business Program Monday, the NACDS leadership underscored the commitment of pharmacies and pharmacy teams to serving, safeguarding and healing the nation, and detailed the industry’s accomplishments, adaptability and resilience in response to the ongoing and historic challenges of the COVID-19
ARLINGTON, Va. – Focused on delivering value to the membership, the National Association of Chain Drug Stores (NACDS) has announced three moves to advance a pro-patient and pro-pharmacy agenda. NACDS is fully integrating its federal legislative, grassroots, political, and strategic communications functions. The Association also is focused on emphasizing a highly collaborative approach to strategic
ARLINGTON, Va. — The Drug Enforcement Administration’s (DEA’s) rulemaking that implements a 2016 law allowing for the partial filling of Schedule II controlled substances is a necessary step to help address the opioid abuse epidemic, yet changes are recommended to ensure success, according to the National Association of Chain Drug Stores. NACDS submitted comments this
ARLINGTON, Va. — Regional pharmacy operators are playing an outsize role in “restoring hope for individuals in communities throughout the country,” National Association of Chain Drug Stores president and CEO Steve Anderson said today. “This industry, and this profession, has said for decades that pharmacies can do even more as health care destinations in enhancing
With the Biden administration and the 117th Congress in place, we asked Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores, to share his thoughts about the current state of the nation’s government and politics, and what it means for retail pharmacy. Implications of last month’s riot on
You may have heard this one-liner popularized in 2020: “In 2015, everyone who answered the standard question ‘where do you see yourself in five years?’ got it wrong.” Given that few people in 2015 would have foreseen themselves five years later in a mask, in quarantine and confronting COVID-19’s many challenges, that comment describes well
Steve Anderson, president and CEO of the National Association of Chain Drug Stores, and Dr. Peter Cressy, Director of Executive Programs at the George Washington Leadership Institute, have a conversation about the challenges facing associations and how leaders of today can learn from leaders of the past.
The National Association of Chain Drug Stores has opened a new front in the battle to maximize the impact of pharmacy care on the well-being of patients and the efficient operation of the health care system. In an extensive set of comments sent to Department of Health and Human Services’ Office of Inspector General by
ARLINGTON, Va.– Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, the National Association of Chain Drug Stores (NACDS) wrote in detailed letters to 15 Medicaid program directors. NACDS also called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain. NACDS made
PALM BEACH, Fla. — The National Association of Chain Drug Stores’ campaign-style approach to the issues crucial for pharmacy value and viability dominated this month’s opening session of the 2019 NACDS Regional Chain Conference. NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the association’s “Access Agenda” — which
The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course
ARLINGTON, Va. – The National Association of Chain Drug Stores has responded to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in health care delivery. NACDS president and CEO Steve Anderson wrote, “This column validates further the competence,
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike. In October, the National Association of Chain Drug Stores was invited to the White House for two bill-signing ceremonies in as many weeks: one for legislation related to drug
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) lauded Congressional leaders for their efforts to empower pharmacists help patients reduce out-of-pocket drug costs. The U.S. House of Representatives approved the Senate-passed versions of the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), thus